Ester Rigol-Planas
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The IL-6 axis in vascular inflammation: effects of IL-6 receptor blockade on vascular lesions from patients with giant-cell arteritis.
Journal: Annals of the rheumatic diseases
Published: February 06, 2025
Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2024
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.
Journal: Molecular cancer therapeutics
Published: March 25, 2022
A single-cell tumor immune atlas for precision oncology.
Journal: Genome research
Published: November 03, 2020
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.
Journal: Nature communications
Published: March 28, 2019
Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.
Journal: Frontiers in immunology
Published: December 14, 2017
Recent advances in our understanding of giant cell arteritis pathogenesis.
Journal: Autoimmunity reviews
Published: May 08, 2017
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.
Journal: Annals of the rheumatic diseases
Published: November 08, 2016
Last Updated: 09/26/2026